Insulin and epidermal growth factor (EGF) stimulate a rapid but transient increase in the amount of GTP bound to Ras that returns to the basal GDP-bound state within 10 -30 min. Although insulin stimulation resulted in a dissociation of the Grb2⅐SOS complex, EGF did not affect the Grb2⅐SOS complex but instead induced dissociation of Grb2-SOS from tyrosine-phosphorylated Shc. The dissociation of Grb2-SOS from Shc was not due to dephosphorylation as Shc remained persistently tyrosine-phosphorylated during this time. Furthermore, there was no decrease in the extent of insulin receptor substrate 1, insulin receptor, or EGF receptor tyrosine phosphorylation. Surprisingly, however, despite the EGF-induced decrease in the amount of Grb2-SOS bound to Shc, the extent of Grb2 associated with Shc remained constant, and there was a concomitant increase in the amount of SOS associated with Grb2. In addition, after the insulin-stimulated dissociation of Grb2 from SOS, EGF treatment induced the reassociation of the Grb2⅐SOS complex. Quantitative immunoprecipitation demonstrated that only a small fraction of the total cellular pool of Grb2 was associated with SOS. Similarly, only a small fraction of SOS and Grb2 were co-immunoprecipitated with Shc. Together, these data suggest the presence of distinct Grb2-SOS pools that are independently utilized by insulin and EGF in their recruitment to tyrosine-phosphorylated Shc.
Insulin and epidermal growth factor (EGF) stimulate a rapid but transient increase in the amount of GTP bound to Ras that returns to the basal GDP-bound state within 10 -30 min. Although insulin stimulation resulted in a dissociation of the Grb2⅐SOS complex, EGF did not affect the Grb2⅐SOS complex but instead induced dissociation of Grb2-SOS from tyrosine-phosphorylated Shc. The dissociation of Grb2-SOS from Shc was not due to dephosphorylation as Shc remained persistently tyrosine-phosphorylated during this time. Furthermore, there was no decrease in the extent of insulin receptor substrate 1, insulin receptor, or EGF receptor tyrosine phosphorylation. Surprisingly, however, despite the EGF-induced decrease in the amount of Grb2-SOS bound to Shc, the extent of Grb2 associated with Shc remained constant, and there was a concomitant increase in the amount of SOS associated with Grb2. In addition, after the insulin-stimulated dissociation of Grb2 from SOS, EGF treatment induced the reassociation of the Grb2⅐SOS complex. Quantitative immunoprecipitation demonstrated that only a small fraction of the total cellular pool of Grb2 was associated with SOS. Similarly, only a small fraction of SOS and Grb2 were co-immunoprecipitated with Shc. Together, these data suggest the presence of distinct Grb2-SOS pools that are independently utilized by insulin and EGF in their recruitment to tyrosine-phosphorylated Shc.
The insulin and epidermal growth factor (EGF) 1 receptors are members of a large family of transmembrane proteins that contain a large extracellular ligand binding domain and an intracellular tyrosine kinase domain (1, 2) . Ligand binding activates the intrinsic tyrosine kinase activity of these receptors resulting in both autophosphorylation and phosphorylation of various intracellular effector proteins (3, 4) . One such family of effector proteins, termed Shc for src homology 2 (SH2) domain-containing ␣2 collagen-related, when tyrosine-phosphorylated on Tyr-317, generates a recognition site for the SH2 domain of Grb2 (5-7). Grb2 is a 23-kDa adapter protein containing a single SH2 domain flanked by two src homology 3 (SH3) domains (8, 9) . The SH3 domains of Grb2 mediate the basal state association with the proline-rich domain of SOS, a guanylnucleotide exchange factor for the p21 GTP-binding protein Ras (10 -14) .
Although these molecular events may account for the increase in GTP-bound Ras, Ras activation is transient and rapidly returns to its basal GDP-bound state (15) (16) (17) (18) . The inactivation of Ras following insulin stimulation appears to result from a feedback serine/threonine phosphorylation of SOS by the Ras/Raf/MEK/ERK pathway (19 -21) . This phosphorylation event directly correlates with a dissociation of the Grb2⅐SOS complex and the return of GTP-bound Ras back to the GDPbound state (21) (22) (23) . EGF also induces a serine/threonine phosphorylation of SOS and a transient activation of Ras; however, EGF stimulation does not result in a decrease in the amount of Grb2 bound to SOS (24, 25) . In contrast, EGF apparently induces a dissociation of the Grb2⅐SOS complex from tyrosinephosphorylated Shc (26 -28) . Thus, although the disruption of the Shc⅐Grb2⅐SOS complex appears to be the mechanism responsible for the inactivation phase of Ras following growth factor stimulation, insulin and EGF utilize different molecular pathways.
To address this issue, we and others (28, 29) have demonstrated that EGF induces a persistent targeting of Grb2 to the EGF receptor, whereas insulin does not induce a stable association of Grb2 with the insulin receptor. Furthermore, inhibition of Grb2 association with the EGF receptor by either expression of an SH2 domain Grb2 mutant or an EGF receptor mutant lacking autophosphorylation sites resulted in an EGFstimulated dissociation of the Grb2⅐SOS complex in an identical manner to insulin (28) . During the course of these studies, we observed several quantitative differences between the amount of Grb2 bound to SOS in the basal versus EGF-stimulated state. Based upon these data we speculated that functionally different pools of Grb2-SOS may be involved in these pathways. In the present article, we demonstrate that only a small fraction of Grb2 is associated with SOS and that this fraction undergoes insulin-stimulated dissociation. In contrast, EGF does not affect this pool of Grb2-SOS but instead recruits an alternative Grb2-SOS pool that undergoes a dissociation from Shc.
EXPERIMENTAL PROCEDURES
Cell Culture-Chinese hamster ovary cells expressing the human insulin and EGF receptors (CHO/IR/ER) were isolated and cultured as described previously (30) . Cells were incubated for 16 h in serum-free media and then incubated with and without 100 nM insulin or 20 nM EGF at 37°C for various times as indicated in the figure legends. The cell extracts were prepared by solubilization in 50 mM Hepes, pH 7.8, 1% Triton X-100, 2.5 mM EDTA, 100 mM sodium fluoride, 10 mM sodium pyrophosphate, 2 mM sodium vanadate, 2 M pepstatin, 0.5 trypsin inhibitory units of aprotinin, 1 mM phenylmethylsulfonyl fluoride, and 10 M leupeptin.
Immunoprecipitation and Immunoblotting-Grb2, SOS, and Shc were immunoprecipitated from whole cell lysates by incubation with 4 g of a Grb2 polyclonal antibody (Santa Cruz Biotechnology), a SOS polyclonal antibody (Santa Cruz Biotechnology), or a Shc polyclonal antibody (Transduction Laboratories) for 2 h at 4°C. The resultant immune complexes were precipitated by incubation with protein ASepharose for 1 h at 4°C. The pellets were washed three times with 0.1% Triton X-100/Tris-buffered saline (20 mM Tris, pH 7.6, 150 mM NaCl), once with Tris-buffered saline, resuspended in SDS-sample buffer (125 mM Tris-HCl, pH 6.8, 20% (v/v) glycerol, 4% (w/v) SDS, 100 mM dithiothreitol, 0.1% (w/v) bromphenol blue), and heated at 100°C for 5 min. Whole cell lysates or immunoprecipitates were separated on reducing 5-15% SDS-polyacrylamide gradient gels and transferred to polyvinylidene difluoride membranes using 1 A for 2 h at 4°C. Immunoblotting of the whole cell lysates or immunoprecipitates was performed using a monoclonal SOS antibody (Transduction Laboratories), a Grb2 antibody (Transduction Laboratories), a Shc antibody (Transduction Laboratories), or the PY20 phosphotyrosine antibody (Santa Cruz Biotechnology).
Quantitative SOS and Shc Immunoprecipitation-Quantitative immunoprecipitation of SOS and Shc was performed by three consecutive rounds of SOS or Shc immunoprecipitation using 3 g of each respective antibody per immunoprecipitation. The samples were incubated for 2 h at 4°C, and the immune complexes were precipitated by incubation with protein A-Sepharose for 1 h at 4°C as described above. The resultant supernatants were then subjected to two additional rounds of antibody addition and precipitation. The immunoprecipitates were pooled, and the final supernatants were subjected to immunoblotting.
Determination of GTP-bound Ras-CHO/IR/ER cells were incubated in serum-and phosphate-free media for 2 h, followed by the addition of 0.2 mCi/ml carrier-free 32 P for 3 h. The cells were either left untreated or stimulated with 100 nM insulin or 20 nM EGF at 37°C for the indicated times. Cells were solubilized in 50 mM Hepes, 1 mM sodium phosphate, pH 7.4, 1% Triton X-100, 100 mM NaCl, 20 mM MgCl 2 , 1 mg/ml bovine serum albumin, 0.1 mM GTP, 0.1 mM GDP, 1 mM ATP, 0.4 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, 10 g/ml leupeptin, 10 g/ml soybean trypsin inhibitor, and 10 mM benzamide. The extract was immunoprecipitated with the ras antibody (Y13-259, Oncogene Science) for 60 min, and the immune complexes were washed 5 times with lysis buffer and 5 times with wash buffer (50 mM Hepes, pH 7.4, 20 mM MgCl 2 , 150 mM NaCl, and 0.005% SDS). Ras-associated guanylnucleotides were eluted in 20 l of 2 mM EDTA, pH 8.0, 2 mM dithiothreitol, 0.2% SDS, 0.5 mM GTP, and 0.5 mM GDP at 65°C for 20 min. Eluted GDP and GTP were separated on polyethyleneimine cellulose plates (Baker) by thin layer chromatography using 1 M KH 2 PO 4 , pH 3.4, as the solvent. Labeled nucleotides were visualized by autoradiography and counted using an AMBIS ␤ detector.
RESULTS

Insulin but Not EGF Induces a Dissociation of the Grb2⅐SOS
Complex-We and others (19, 21) have previously observed that various agents (insulin, platelet-derived growth factor, v-Ras, v-Raf, and serum) that activate the Ras/Raf/MEK/ERK pathway result in a feedback serine/threonine phosphorylation of SOS and dissociation of the Grb2⅐SOS complex. Surprisingly however, although EGF stimulation also activated the Ras/Raf/ MEK/ERK pathway and the serine/threonine phosphorylation of SOS, there was no decrease in the amount of the Grb2⅐SOS complex in fibroblast cell lines or in 3T3L1 adipocytes (24 -28) . Consistent with these findings, Chinese hamster ovary cells expressing both the human insulin and EGF receptors (CHO/ IR/ER) demonstrated an insulin-stimulated decrease in the amount of SOS protein that was co-immunoprecipitated with Grb2 (Fig. 1A, lanes 1 and 2) . In direct contrast to insulin, 30 min of EGF treatment resulted in a significant increase in the amount of SOS protein that was co-immunoprecipitated with Grb2 (Fig. 1A, lane 3) . As a control, the immunoprecipitates were also subjected to Grb2 immunoblotting to confirm that equal amounts of Grb2 were immunoprecipitated under these conditions (Fig. 1B, lanes 1-3) .
Ras Activation Is Transient following Both Insulin and EGF Stimulation-It has previously been suggested that one mechanism contributing to the inactivation of Ras following insulin stimulation is the dissociation of the Grb2⅐SOS complex (22, 23) . CHO/IR/ER cells stimulated with insulin also display this characteristic time-dependent activation/inactivation of Ras GTP binding (Fig. 2) . Maximal GTP-bound Ras was detected approximately 3 min following insulin treatment which then gradually returned to the GDP-bound state within 30 min. Even though EGF stimulation did not result in a dissociation of the Grb2⅐SOS complex, and in fact increased the amount of SOS bound to Grb2, there was a similar time-dependent activation/inactivation of Ras. Maximal GTP-bound Ras occurred by 1 min of EGF treatment followed by a rapid recovery to the basal GDP-bound state by 5 min. The greater increase in the extent and amount of time that Ras remained in the activated GTP state following insulin versus EGF treatment probably reflects the different extent of insulin and EGF receptor expression present in these cells. Nevertheless, these data suggest that the association state of the Grb2⅐SOS complex in EGF-stimulated cells could not account for the inactivation phase of Ras.
Insulin and EGF Stimulate Persistent Tyrosine Phosphorylation-In some systems, EGF stimulation has been reported to result in a rapid disappearance of the EGF receptor from the cell surface concomitant with a decrease in tyrosine phosphorylation (25, 31). Thus, it was possible that a transient EGF receptor autophosphorylation was responsible for the transient activation of Ras despite the inability of EGF to induce dissociation of the Grb2⅐SOS complex. To determine the EGF receptor tyrosine autophosphorylation state under these conditions, phosphotyrosine immunoblotting was performed (Fig. 3) . In the unstimulated state there was a very low level of phosphotyrosine-reactive proteins in the CHO/IR/ER cells (Fig. 3A, lane  1) . However, EGF treatment resulted in a rapid tyrosine phosphorylation of the EGF receptor that remained persistent from 1 to 120 min (Fig. 3A, lanes 2-8) . It is interesting to note that there was a progressive reduction in gel mobility of the EGF receptor consistent with secondary serine/threonine phosphorylation. Similar to EGF, insulin stimulation resulted in a rapid tyrosine phosphorylation of the insulin receptor ␤ subunit and IRS1 (Fig. 3B, lanes 1 and 2) . Furthermore, there was no significant decline in the extent of insulin receptor or IRS1 tyrosine phosphorylation (Fig. 3B, lanes 3-8) . These data indicate that the transient nature of Ras activation is unlikely to be accounted for by transient tyrosine phosphorylation of either IRS1, the insulin receptor, or EGF receptor.
Insulin and EGF Stimulate a Persistent Tyrosine Phospho- rylation of Shc-Several studies have demonstrated that the Shc-Grb2⅐SOS complex is probably the major pathway accounting for growth factor activation of Ras (32, 33) . Since it is difficult to detect the tyrosine phosphorylation of Shc in whole cell extracts, we next immunoprecipitated Shc from extracts of insulin-and EGF-stimulated cells (Fig. 4) . In the absence of hormone stimulation there was no detectable tyrosine phosphorylation of the 46-, 52-, or 66-kDa isoforms of Shc (Fig. 4A, lanes  1 and 7) . In contrast, 1 min of insulin or EGF stimulation markedly increased the extent of Shc tyrosine phosphorylation (Fig. 4A, lanes 2 and 8) . In the case of insulin treatment, there was a small but continuous increase in the extent of Shc tyrosine phosphorylation over the 60-min time course examined (Fig. 4A, lanes 2-6) . EGF stimulation resulted in maximal Shc tyrosine phosphorylation between 1 and 10 min (Fig. 4A, lanes  8 -10) . Although there was a small decline in the amount of Shc tyrosine phosphorylation at 30 and 60 min following EGF stimulation (Fig. 4A, lanes 11 and 12) , this occurred significantly later than the 5 min required for the recovery of Ras back to the GDP-bound state (Fig. 2) . As a control for the Shc immunoprecipitation, Shc immunoblotting demonstrated approximately equivalent amounts of Shc protein present in the immunoprecipitates (Fig. 4B, lanes 1-12) . Thus, these data demonstrate that the insulin receptor, EGF receptor, IRS1, and Shc all remained tyrosine-phosphorylated during the same time in which Ras returned to the inactive GDP-bound state.
EGF Induces a Dissociation of SOS from Shc-Even though Shc remained persistently tyrosine-phosphorylated over the time frame of Ras inactivation, the serine/threonine phosphorylation of SOS could affect the interaction of the Grb2⅐SOS complex with Shc. To assess this issue, we next determined the association of Shc with SOS following insulin and EGF stimulation (Fig. 5) . As expected, in the unstimulated state there was no significant co-immunoprecipitation of SOS with Shc since Shc was not tyrosine-phosphorylated and therefore could not associate with the Grb2⅐SOS complex (Fig. 5A, lane 1) . However, following 1 min of insulin stimulation, there was a detectable amount of SOS protein present in the Shc immunoprecipitate (Fig. 5A, lane 2) . Since longer incubation with insulin induces a dissociation of Grb2 from SOS, following 30 min of insulin stimulation there was a concomitant decrease in the amount of SOS co-immunoprecipitated with Shc (Fig. 5A, lane  3) . Consistent with the EGF-induced increase in Grb2-associated SOS (Fig. 1 ), 1 min of EGF stimulation resulted in a greater amount of SOS co-immunoprecipitated with Shc compared with insulin-stimulated cells (Fig. 5A, lane 4) . Even though longer treatment with EGF did not induce a dissociation of SOS from Grb2, incubation with EGF for 30 min decreased the amount of SOS associated with Shc (Fig. 5A, lane  5) . A Shc immunoblot of the Shc immunoprecipitate demonstrated that these differences were not due to variable immunoprecipitation of Shc (Fig. 5B, lanes 1-5) . Thus insulin induces a dissociation of SOS from Grb2, hence SOS from Shc, whereas EGF stimulates an uncoupling between SOS and Shc without disrupting the Grb2⅐SOS complex.
To examine the association of Shc with Grb2, we also performed a Grb2 immunoblot on the Shc immunoprecipitates (Fig. 5C ). As expected, since Shc was not tyrosine-phosphorylated in the unstimulated state, there was a relatively low level of associated Grb2 protein (Fig. 5C, lane 1) . In contrast, following 1 or 30 min of insulin stimulation there was a marked increase in the amount of co-immunoprecipitated Grb2 (Fig.  5C, lanes 2 and 3) . The persistent association of Shc with Grb2 was consistent with the stable tyrosine phosphorylation of Shc and with the insulin-stimulated dissociation of the Grb2⅐SOS complex but not the Shc⅐Grb2 complex. Surprisingly however, EGF stimulation for either 1 or 30 min had no significant effect on the amount of Grb2 co-immunoprecipitated with Shc (Fig.  5C, lanes 4 and 5) . The apparent stable association of Grb2 with Shc following EGF stimulation was surprising given the persistent association of Grb2 with SOS (Fig. 1, lane 3) and a concurrent dissociation of SOS from Shc.
SOS Associates with a Small Fraction of the Cellular Grb2
Pool-In order to account for this discrepancy, we speculated that different pools of Grb2 may be associated with Shc and/or SOS. To address this possibility, we quantitatively immunoprecipitated SOS and determined the relative amount of Grb2 that was co-immunoprecipitated (Fig. 6 ). The SOS protein was readily immunoprecipitated from cell extracts and displayed the characteristic decrease in SDS-polyacrylamide gel electrophoretic mobility due to serine/threonine phosphorylation following 30 min of both insulin and EGF treatment (Fig. 6A,  lanes 1-5) . The SOS immunoprecipitation depleted the majority of the SOS protein as determined by a SOS immunoblot of the resultant supernatants (Fig. 6B, lanes 1-5) compared with equivalent amounts of the whole cell extracts (Fig. 6B, lanes  6 -8) . In contrast, immunodepletion of SOS from the cell ex- tracts had no significant effect on the amount of Grb2 protein remaining in the supernatants compared with the whole cell extracts (Fig. 6C, lanes 1-8) . Under these conditions, the large amount of SOS antibody used to immunoprecipitate the SOS protein precluded our detection of Shc due to the presence of the antibody heavy chain (data not shown). In any case, these data demonstrate that only a small fraction of the total cellular pool of Grb2 was associated with SOS.
Shc Associates with a Small Fraction of the Total Cellular Pools of Grb2 and SOS-To determine the relative extent of
Shc that was associated with SOS, we next performed quantitative immunoprecipitations of Shc and assessed the amount of SOS and Grb2 immunodepleted from the cell extracts (Fig. 7) . Immunoprecipitation of Shc demonstrated the presence of approximately equal amounts of the three Shc isoforms (66, 52, and 46 kDa) in the immunopellets from unstimulated, insulin-, and EGF-stimulated cells (Fig. 7A, lanes 1-5) . The supernatants remaining after the Shc immunoprecipitation were cleared of the Shc protein (Fig. 7B, lanes 1-5) compared with the whole cell extracts (Fig. 7B, lanes 6 -8) . In contrast, the near-complete immunodepletion of Shc did not reduce the amount of SOS protein remaining in the supernatants (Fig. 7C,  lanes 1-5) compared with the whole cell extracts (Fig. 7C, lanes  6 -8) . Similarly, the immunoprecipitation of Shc did not significantly affect the amount of Grb2 protein in the cell extracts (Fig. 7D, lanes 1-8) . Together, these data demonstrate that only a small fraction of the total cellular pool of SOS and Grb2 were associated with Shc following both insulin and EGF stimulation.
EGF Treatment Prevents Grb2-SOS Dissociation by Insu-
lin-Recently it was reported that Ras desensitization occurred in a homologous manner such that following insulin-stimulated activation/inactivation subsequent treatment with EGF, but not insulin, could reactivate Ras GTP binding (25) . Based upon the large excess of Grb2 and SOS that were not complexed and remained unassociated, it was possible that EGF stimulation resulted in the formation and/or stabilization of the Grb2⅐SOS complex, thereby overcoming the effect of insulin to dissociate Grb2 from SOS. To examine this possibility, Grb2 was immunoprecipitated from extracts isolated from unstimulated or cells stimulated with various combinations of insulin and EGF (Fig. 8) . Cell extracts from unstimulated cells demonstrated the co-immunoprecipitation of SOS with Grb2 (Fig. 8, lanes 1 and  8) . As previously observed (Fig. 1) , EGF treatment for 30 or 60 min increased the amount of SOS that was co-immunoprecipitated with Grb2 (Fig. 8, lanes 2 and 3) . In addition, insulin treatment for 30 or 60 min induced the expected dissociation of SOS from Grb2 (Fig. 8, lanes 5 and 6) . However, pretreatment of the cells with EGF for 30 min followed by an additional 30 min of insulin resulted in only a small decrease in the association state between Grb2 and SOS (Fig. 8 , compare lane 4 with lane 1). Furthermore, pretreatment of the cells for 30 min with insulin followed by a 30-min incubation with EGF resulted in a recovery of the Grb2⅐SOS complex compared with the effect of insulin alone (Fig. 8, compare lane 6 with lane 7 ). These data demonstrate that EGF stimulation can induce the association of Grb2 with SOS following the insulin-stimulated dissociation of the Grb2⅐SOS complex.
DISCUSSION
Over the past several years a complex series of intracellular events have been defined which together account for the growth factor receptor activation of Ras. In this mechanism, receptor-mediated tyrosine phosphorylation of Shc generates a specific recognition motif for the SH2 domain of Grb2, a 23-kDa adapter protein containing a single SH2 domain flanked by two SH3 domains (8, 9) . The SH3 domains of Grb2 direct the association with the carboxyl-terminal proline-rich domain of SOS, a 170-kDa guanylnucleotide exchange factor for Ras (7, 8, 24, 34 -37) . Since expression of plasma membrane-targeted forms of SOS result in the constitutive activation of Ras, it was suggested that in the basal state the Grb2⅐SOS complex was sequestered from Ras (38, 39) . Thus, tyrosine phosphorylation of Shc and/or the EGF receptor itself might function in the appropriate targeting of the Grb2⅐SOS complex to the plasma membrane location of Ras, hence allowing for the productive exchange of GDP for GTP. More recently, several studies have suggested that the carboxyl-terminal domain of SOS functions as an auto-inhibitory domain that may be derepressed by the binding of Grb2 (39 -41) . Although the role of Grb2 in mediating alterations in SOS activity and/or subcellular localization is 1 and 7) and in the presence of 100 nM insulin or 20 nM EGF for 1 (lanes 2 and 8), 3 (lanes 3 and  9), 10 (lanes 4 and 10), 30 (lanes 5 and 11) , and 60 (lanes 6 and 12) min. Whole cell detergent extracts were prepared and immunoprecipitated with an Shc polyclonal antibody. The immunoprecipitates were then immunoblotted with either the PY20 phosphotyrosine antibody (A) or an Shc monoclonal antibody (B) as described under "Experimental Procedures." This is a representative result from three experiments. not entirely understood, it is clear that the interaction of SOS with Grb2 plays an important role in regulating the activation state of Ras.
In contrast to the activation of Ras, the mechanisms that underlie the return of Ras back to the GDP-bound state have remained enigmatic. The hydrolysis of Ras-bound GTP to GDP can be catalyzed by several GTPase-activating proteins including p100 RasGAP, p120 RasGAP, and neurofibromin (42) . Thus, the activation state of Ras is defined by the relative functional activities of SOS and RasGAPs. However, previous studies have not observed a significant effect of insulin on RasGAP activity, phosphorylation, and/or subcellular localization (43, 44) . In addition, EGF has been reported to inhibit RasGAP activity which is directly opposite to what is required for the inactivation of Ras (45) . Thus, it is unlikely that Ras-GAP plays a major role in the inactivation phase following growth factor-stimulated Ras activation.
To address this issue, we and others (19, 21) have recently reported that insulin stimulation results in a dissociation of the Grb2⅐SOS complex with a time course that parallels the inactivation of Ras. Furthermore, inhibition of Grb2-SOS dissociation, via specific blockade of SOS serine/threonine phosphorylation, prolonged the time Ras remained in the active GTP- . Whole cell detergent extracts were prepared and immunoprecipitated with a Grb2 antibody as described under "Experimental Procedures." The Grb2 immunoprecipitates were then immunoblotted with an SOS antibody. This is a representative result from two experiments.
bound state (22, 23) . These data support a role for an insulinstimulated feedback uncoupling of Grb2 from SOS as one potential mechanism responsible for the transient nature of Ras activation. In contrast, recent studies on EGF regulation of Ras have reported marked discrepancies with regard to ShcGrb2-SOS interactions. Although one study observed an EGFinduced dissociation of Grb2 from SOS, several others have not detected any decrease in the amount of the Grb2⅐SOS complex (23, (25) (26) (27) (28) . In contrast, another report suggested that the Grb2⅐SOS complex dissociated from Shc due to its transient tyrosine phosphorylation (25) , whereas others observed a reduction in affinity of the Grb2⅐SOS complex for tyrosine-phosphorylated Shc and the EGF receptor (26 -28) .
The data presented in this article demonstrate that the overall tyrosine phosphorylation state of Shc, IRS1, insulin receptor, and EGF receptor remains relatively constant over the same time frame of Ras inactivation. Although we have not determined potential changes in specific tyrosine phosphorylation sites, Shc has only one major tyrosine phosphorylation site at Tyr-317 (6, 46) . Thus our results are more consistent with the studies demonstrating an EGF-stimulated dissociation of the Grb2⅐SOS complex from persistently tyrosine-phosphorylated Shc without any uncoupling of the Grb2⅐SOS complex itself. In fact, we typically observe an EGF-stimulated increase in the amount of SOS bound to Grb2. This finding is similar to that reported for T cell receptor activation which enhanced the formation of Grb2 with SOS prior to the association of the Grb2⅐SOS complex with tyrosine-phosphorylated Shc (47) . In any case, the uncoupling of either Grb2 from SOS and/or Shc from the Grb2⅐SOS complex provides a molecular pathway accounting for the transient activation of Ras following insulin or EGF stimulation, respectively.
Although it was previously reported that a small fraction of the total cellular pool of SOS was associated with Shc following insulin stimulation (48), we were surprised to find that the Grb2⅐SOS complex only accounted for a small fraction of the cellular Grb2 protein. In addition, tyrosine-phosphorylated Shc also bound a minor fraction of Grb2. Thus, in the growth factor-stimulated state the majority of the Shc, Grb2, and SOS proteins remain either uncomplexed or are associated with other as yet unidentified effector proteins. There are two possibilities to account for EGF-stimulated dissociation of the Grb2⅐SOS complex from Shc without any apparent change in the amount of Grb2 bound to Shc. EGF stimulation could result in a delayed tyrosine phosphorylation of another protein that competes with tyrosine-phosphorylated Shc for the Grb2⅐SOS complex. Alternatively, we hypothesize the existence of different Grb2 pools, one smaller pool that associates with Shc in a Grb2⅐SOS complex and a second larger pool that binds tyrosine-phosphorylated Shc independent of SOS. This observation would be consistent with a recent study indicating the presence of distinct subcellular compartmentalized pools of Shc (49) .
The differential utilization of distinct pools of Grb2 and SOS can also account for the ability of heterologous hormones to activate Ras after homologous Ras desensitization. For example, following insulin-induced inactivation of Ras, readdition of insulin fails to stimulate GTP binding to Ras. This is a specific homologous desensitization process since under the same conditions addition of EGF stimulates the normal pattern of Ras activation/inactivation (25) . The ability of EGF to stimulate the re-assembly of the Grb2⅐SOS complex following insulin-induced dissociation provides a pathway for Ras activation by a heterologous growth factor while maintaining desensitization against the homologous hormone. Currently, we are investigating the molecular mechanism responsible for the ability of EGF to override the effects of insulin on Grb2-SOS interactions. Furthermore, whether or not other growth factor-activated tyrosine kinase receptor signaling pathways can also modify the insulin-induced dissociation of the Grb2⅐SOS complex remains to be determined.
